Navigation Links
American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling
Date:9/2/2010

BETHESDA, Md., Sept. 2 /PRNewswire-USNewswire/ -- The American Society for Biochemistry and Molecular Biology expressed its disapproval and disappointment this week in response to the Aug. 23 ruling in the U.S. District Court for the District of Columbia that granted a preliminary injunction barring federal funding of embryonic stem-cell research.

In a statement, the society said the decision, which came in response to a lawsuit filed by two adult stem-cell researchers, effectively halts human embryonic stem-cell research in the United States and "represents a crossroads in American scientific policy."

The society, which represents more than 12,000 scientists in both academia and industry worldwide, urged Congress to act swiftly to pass legislation that will restore federal funding to embryonic stem-cell researchers as to not further delay "potential medical cures for millions of sick Americans."

Meanwhile, the society said the ruling undercuts the "gold standard" peer-review process by allowing the merits of research projects to be determined by those on the judicial bench instead of those working at the laboratory bench:  "Funding of basic biomedical research is not a zero-sum game in which particular lines of research are supported at the expense of others; rather, the system has evolved so that each proposal is evaluated on both its merits and its future benefits for easing the burden of disease."

The peer-review process "is by nature competitive," the statement said, and has "resulted in new biomedical methodologies and technologies that continue to benefit society at large."

"Constraining funding to a limited subset of applications will doubtless limit discovery and hurt those who rely on those discoveries the most."

ASBMB underscored its support for existing guidelines developed and enforced by the National Institutes of Health and for U.S. House Resolution 4808, commonly known as the Stem Cell Research Advan
'/>"/>

SOURCE American Society for Biochemistry and Molecular Biology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
2. American Humane Association Announces Joy Mench, Ph.D., Joins the Scientific Advisory Committee of the American Humane Certified® Farm Animal Program
3. Bariatric Advantage to Attend American Society of Metabolic and Bariatric Surgery (ASMBS) Conference
4. Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando, FL, June 25-29, 2010
5. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
6. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
7. NeoStem Selected to Present at American Society for Apheresis
8. Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting
9. Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting
10. Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting
11. NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Rootstown, OH (PRWEB) January 22, 2015 Crystal ... announced today that it has received AOAC-PTM Certifications for the ... O111, O121, and O145; collectively referred to as STEC or ... at 1 colony forming unit (cfu) per 325 g of ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)...   GenoSpace , a precision medicine software company that has ... use of genomic, imaging and other biomedical data in research ... Munson , CEO of Aspera, an IBM Company, to its ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to welcome ...
(Date:12/24/2014)... 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), a ... today that the Company closed its previously announced ... Jack W. Schuler , Birchview Fund LLC ... million, before offering expenses.  The proceeds will be ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... Calif., Aug. 31 Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... 2009 Annual Meeting of Stockholders on Monday, September 28, 2009 at ... Blvd., Suite 200, Novato, California. All stockholders of record as of ... meeting and all stockholders of Raptor are invited to attend such ...
... , , , ... 31 Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a ... novel antibiotics for the treatment of acute care antibiotic-resistant infections, ... several computationally designed series of chemically unique compounds demonstrating efficacy ...
... , , , ... BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, ... organs, today announced the launch of its BloodStor biopreservation media ... cryopreservation of umbilical cord blood stem cells, as well as ...
Cached Biology Technology:Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders 2Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders 3Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria 2Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria 3BloodStor(TM) Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 2BloodStor(TM) Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 3
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... the skeletons of organisms contain small amounts of impurity ... elements provide important clues to past environments, a considerable ... contents to the ancient environments in which an organism ... Science magazine, Allison Stephenson, a Ph.D. candidate ...
... of the mystery underlying a childhood eye disease. New research ... missing or extra pieces of DNA. The missing or extra ... of A research team had previously shown how they play a ... disease that can lead to blindness. In their current study, published ...
... not food allergies at all. This is what Cornelia ... in a study with 419 patients, as presented in ... (Dtsch Arztebl Int 2008; 105[42]: 715-23). http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=61998 ... only confirmed in 214 patients. Thus, food allergies are ...
Cached Biology News:Bare bones of crystal growth: Biomolecules enhance metal contents in calcite 2
... PEP-152 is a 17 amino acid synthetic peptide whose sequence is ... (amino to carboxy terminus): C - N(217) - Q - ... - A - T - P - N - Y - ... may be used for neutralization and control experiments with the polyclonal ...
... a novel target for which no antibody exists? ... custom antibodies for a variety of pharmaceutical, biotech ... to put our technology and expertise in antibody ... to our patented RabMAb development technology , High ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
Biology Products: